Get started
Tango Therapeutics, Inc.Tango Therapeutics, Inc.Tango Therapeutics, Inc.

Tango Therapeutics, Inc.

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsOptionsETFs
Full chart
Full chart

Compare with Tango Therapeutics, Inc.



Key stats


Market capitalization
‪4.65 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.82 USD
Net income (FY)
‪−101.59 M‬ USD
Revenue (FY)
‪62.38 M‬ USD
Shares float
‪119.32 M‬
Beta (1Y)
0.55

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
137
Change (1Y)
−18−11.61%
Revenue / Employee (1Y)
‪455.36 K‬ USD
Net income / Employee (1Y)
‪−741.56 K‬ USD

Profile


Sector
Health Technology
Industry
Biotechnology
CEO
Malte Peters
Website
tangotx.com
Headquarters
Boston
Founded
2017
IPO date
Sep 3, 2020
ISIN
US87583X1090
CUSIP
87583X109
FIGI
BBG00WFDDRS0
Identifiers
ISIN US87583X1090
CFI code
ESVUFR
Tango Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in discovering and delivering precision cancer medicines. It also identifies novel targets and develops new drugs directed at tumor suppressor gene loss in defined patient populations with high unmet medical need. The company was founded by Alan Ashworth, William G. Kaelin Jr., Jose Baselga, Antoni Ribas and Barbara Weber in 2017 and is headquartered in Boston, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


IWM
iShares Russell 2000 Index Fund
Weight0.13%
Market value‪105.83 M‬
XBI
State Street SPDR S&P Biotech ETF
Weight0.79%
Market value‪80.50 M‬
VXF
Vanguard Extended Market ETF
Weight0.04%
Market value‪44.35 M‬
IWO
iShares Russell 2000 Growth Fund
Weight0.26%
Market value‪37.35 M‬
VTWO
Vanguard Russell 2000 ETF
Weight0.13%
Market value‪25.34 M‬
IBB
iShares Biotechnology ETF
Weight0.27%
Market value‪24.95 M‬
SCHA
Schwab U.S. Small-Cap ETF
Weight0.07%
Market value‪16.18 M‬
FESM
Fidelity Enhanced Small Cap Core ETF
Weight0.17%
Market value‪10.03 M‬
VHT
Vanguard Health Care ETF
Weight0.04%
Market value‪8.79 M‬
ZPRR
State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Ptg USD
Weight0.12%
Market value‪6.68 M‬
R2EH
State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR
Weight0.12%
Market value‪6.68 M‬

Explore more ETFs 

Frequently asked questions


The current price of TNGX is 27.54 USD — it has increased by 3.33% in the past 24 hours. Watch Tango Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Tango Therapeutics, Inc. stocks are traded under the ticker TNGX.
TNGX stock has fallen by −6.42% compared to the previous week, the month change is a −11.07% fall, over the last year Tango Therapeutics, Inc. has showed a 294.56% increase.
We've gathered analysts' opinions on Tango Therapeutics, Inc. future price: according to them, TNGX price has a max estimate of 69.00 USD and a min estimate of 24.00 USD. Watch TNGX chart and read a more detailed Tango Therapeutics, Inc. stock forecast: see what analysts think of Tango Therapeutics, Inc. and suggest that you do with its stocks.
TNGX reached its all-time high on Jun 17, 2026 with the price of 34.39 USD, and its all-time low was 1.03 USD and was reached on May 8, 2025. View more price dynamics on TNGX chart.
See other stocks reaching their highest and lowest prices.
TNGX stock is 6.69% volatile and has beta coefficient of 0.55. Track Tango Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Tango Therapeutics, Inc. there?
Today Tango Therapeutics, Inc. has the market capitalization of ‪4.50 B‬, it has increased by 0.71% over the last week.
Yes, you can track Tango Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Tango Therapeutics, Inc. is going to release the next earnings report on Aug 12, 2026. Keep track of upcoming events with our Earnings Calendar.
TNGX earnings for the last quarter are −0.32 USD per share, whereas the estimation was −0.31 USD resulting in a −2.01% surprise. The estimated earnings for the next quarter are −0.32 USD per share. See more details about Tango Therapeutics, Inc. earnings.
Tango Therapeutics, Inc. revenue for the last quarter amounts to 0.00 USD, despite the estimated figure of ‪578.09 K‬ USD. In the next quarter, revenue is expected to reach 0.00 USD.
TNGX net income for the last quarter is ‪−45.51 M‬ USD, while the quarter before that showed ‪−38.75 M‬ USD of net income which accounts for 0.00% change. Track more Tango Therapeutics, Inc. financial stats to get the full picture.
No, TNGX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 21, 2026, the company has 137 employees. See our rating of the largest employees — is Tango Therapeutics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Tango Therapeutics, Inc. EBITDA is ‪−115.41 M‬ USD, and current EBITDA margin is −174.74%. See more stats in Tango Therapeutics, Inc. financial statements.
Like other stocks, TNGX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Tango Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Tango Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Tango Therapeutics, Inc. stock shows the buy signal. See more of Tango Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.